BML-190
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]-1-morpholin-4-ylethanone | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 2854-32-2 |
| ATC code | ? |
| PubChem | CID 2415 |
| ChemSpider | 2321 |
| Chemical data | |
| Formula | C23H23ClN2O4 |
| Mol. mass | 426.892 |
|
|
|
|
| |
|
BML-190 (Indomethacin morpholinylamide) is a drug used in scientific research that acts as a selective CB2 inverse agonist.[1] BML-190 is structurally derived from the NSAID indomethacin but has a quite different biological activity.[2] The activity produced by this compound is disputed, with some sources referring to it as a CB2 agonist rather than an inverse agonist;[3][4] this may reflect an error in classification, or alternatively it may produce different effects in different tissues, more research is required to resolve this dispute.
References[edit]
- ^ New, DC; Wong, YH (2003). "BML-190 and AM251 act as inverse agonists at the human cannabinoid CB2 receptor: signalling via cAMP and inositol phosphates". FEBS Letters 536 (1–3): 157–60. doi:10.1016/S0014-5793(03)00048-6. PMID 12586356.
- ^ Klegeris, A; Bissonnette, CJ; McGeer, PL (2003). "Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor". British Journal of Pharmacology 139 (4): 775–86. doi:10.1038/sj.bjp.0705304. PMC 1573900. PMID 12813001.
- ^ Melck, D; De Petrocellis, L; Orlando, P; Bisogno, T; Laezza, C; Bifulco, M; Di Marzo, V (2000). "Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation". Endocrinology 141 (1): 118–26. doi:10.1210/en.141.1.118. PMID 10614630.
- ^ Scutt, A; Williamson, EM (2007). "Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors". Calcified tissue international 80 (1): 50–9. doi:10.1007/s00223-006-0171-7. PMID 17205329.
| This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |